ME02086B - Compositions et methodes de traitement et de prevention d'une maladie associee a l'integrine alpha v beta 5 - Google Patents

Compositions et methodes de traitement et de prevention d'une maladie associee a l'integrine alpha v beta 5

Info

Publication number
ME02086B
ME02086B MEP-2013-336A MEP33613A ME02086B ME 02086 B ME02086 B ME 02086B ME P33613 A MEP33613 A ME P33613A ME 02086 B ME02086 B ME 02086B
Authority
ME
Montenegro
Prior art keywords
integrin
beta
alpha
compositions
treating
Prior art date
Application number
MEP-2013-336A
Other languages
German (de)
English (en)
Unknown language (me)
Inventor
Dean Sheppard
Amha Atakilit
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Priority claimed from EP05763460.2A external-priority patent/EP1734996B1/fr
Publication of ME02086B publication Critical patent/ME02086B/fr

Links

MEP-2013-336A 2004-04-02 2005-03-30 Compositions et methodes de traitement et de prevention d'une maladie associee a l'integrine alpha v beta 5 ME02086B (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55917504P 2004-04-02 2004-04-02
EP05763460.2A EP1734996B1 (fr) 2004-04-02 2005-03-30 Compositions et methodes de traitement et de prevention d'une maladie associee a l'integrine alpha v beta 5
PCT/US2005/011222 WO2005094391A2 (fr) 2004-04-02 2005-03-30 COMPOSITIONS ET METHODES DE TRAITEMENT ET DE PREVENTION D'UNE MALADIE ASSOCIEE A L'INTEGRINE αVβ5

Publications (1)

Publication Number Publication Date
ME02086B true ME02086B (fr) 2014-02-28

Family

ID=49078157

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2013-336A ME02086B (fr) 2004-04-02 2005-03-30 Compositions et methodes de traitement et de prevention d'une maladie associee a l'integrine alpha v beta 5

Country Status (2)

Country Link
ME (1) ME02086B (fr)
SI (1) SI1734996T1 (fr)

Also Published As

Publication number Publication date
SI1734996T1 (sl) 2013-08-30

Similar Documents

Publication Publication Date Title
HK1216080A1 (zh) 用於治療或預防草酸鹽相關疾病的組合物和方法
HRP20130782T1 (en) Methods and compositions for treating and preventing disease associated with alpha v beta 5 integrin
EP1908779A4 (fr) Dérivés de thymosine beta 4 et utilisation
PT1920065T (pt) Anticorpos anti-alfavbeta6 e suas utilizações
IL178390A0 (en) Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
TWI348891B (en) Composition for preventing plant diseases and method for preventing the diseases
EP1742640A4 (fr) Methodes et compositions de traitement de maladies et de troubles associes a une fonction mitochondriale
EP1827389A4 (fr) Compositions a nanoparticules a liberation prolongee et procedes d'utilisation
EP1737482A4 (fr) Compositions et methodes de traitement de maladies
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
EP1680009A4 (fr) Compositions et procedes pour le diagnostic et de traitement de troubles mentaux
EP1589996A4 (fr) Preparation d'anticorps anti-integrine alpha beta 3 et utilisations associees
EP1978034A4 (fr) Anticorps anti-periostine et composition pharmaceutique pour prevenir ou traiter une maladie liee a la periostine contenant cet anticorps
ZA200707407B (en) Composition for preventing plant diseases and method for preventing the diseases
PL1921077T3 (pl) Środek do zapobiegania i/lub leczenia zaburzenia snu
EP1755537A4 (fr) Procédés et compositions servant à prévenir ou à traiter des maladies parodontales
EP1512415A4 (fr) Composition leurre pour traiter et prevenir une affection inflammatoire
AU2003212850A8 (en) Methods and compositions for treating cardiovascular disease
IL178598A0 (en) Skin-protecting alkalinity-controlling composition and the use thereof
EP1583966A4 (fr) Methodes et compositions pour traiter les maladies cardio-vasculaires au moyen de genes 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061,17662,1468,12282, 6350, 9035,1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123,12788,17729, 65552,1261, 21476, 33770, 9380, 2569654, 33
PL1762219T3 (pl) Fotoochronne i/lub fotoimmunoochronne kompozycje do skóry i ich zastosowania
EP1807067A4 (fr) Activateur de la sphingosine kinase et agent de traitement de maladies cutanees comprenant celui-ci
HK1075272A1 (en) Dye composition and the use thereof
ME02086B (fr) Compositions et methodes de traitement et de prevention d'une maladie associee a l'integrine alpha v beta 5
EP1850827A4 (fr) Composition pour traiter et prevenir la parodontopathie et son procede d'utilisation